Research & Development
Pharos Capital sells TechLab to SSI Diagnostica
TechLab produces tests for infectious diseases, intestinal inflammation, and parasites, as well as gastrointestinal conditions such as inflammatory bowel disease, irritable bowel syndrome, and Escherichia coli infection. It also offers a test for Clostridioides difficile called Quik Chek, according to Pharos Capital.
August 21, 2022
Coated, folded paper creates mobile lab for field tests
The coated paper worked significantly more efficiently and reliably than any type of dry, uncoated paper when testing biological materials in the field -- for example, for use following a natural disaster, wrote Daniel Regan, a research and development engineer at the University of Maine, and colleagues in the journal, a publication of the American Institute of Physics.
August 20, 2019
iCubate's iC-GN Gram-negative assay clears FDA
Bacteria picked up by the iC-GN test include Acinetobacter baumannii complex, Escherichia coli, and Klebsiella pneumoniae, while the antibiotic resistance markers screened by the test include K. pneumoniae carbapenemase (KPC) and New Delhi metallo-beta-lactamase (NDM). Testing takes from two to three minutes, with results available in from 3 to 4.5 hours, according to the company.
July 14, 2019
T2Bacteria panel proves itself, but will hospitals buy in?
The prospective study of 1,427 patients in 11 centers tested the sensitivity, specificity, and speed of the T2Bacteria panel, which is an insert for T2 Biosystems' T2Dx miniaturized magnetic resonance instrument. The system directly tests blood for five types of bacteria ("ESKAPE pathogens") that cause bloodstream infections (BSI): Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli.
May 13, 2019
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
Serum protein in study predicted which patients might die without a liver transplant
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
Page 1 of 1